SATS: A mutational signature analyzer of targeted sequenced tumors
Lee, D.; Hua, M.; Wang, D.; Song, L.; Zhang, T.; Yu, K.; Yang, X. R.; Chanock, S. J.; Shi, J.; Landi, M. T.; Zhu, B.
Show abstract
Tumor mutational signatures are informative for cancer diagnosis and treatment. However, targeted sequencing, commonly used in clinical settings, lacks specialized analytical tools and a dedicated catalogue of mutational signatures. Here, we introduce SATS, a scalable mutational signature analyzer for targeted sequencing data. SATS leverages tumor mutational burdens to identify and quantify signatures in individual tumors, overcoming the challenges of sparse mutations and variable gene panels. Validations across simulated data, pseudo-targeted sequencing data, and matched whole-genome and targeted sequencing samples show that SATS can accurately detect common mutational signatures and estimate their burdens. Applying SATS to 111,711 tumors from the AACR Project GENIE, we created a pan-cancer mutational signature catalogue specific to targeted sequencing. We further validated signatures in lung, breast and colorectal cancers using an additional 16,774 independent samples. This signature catalogue is a valuable resource for estimating signature burdens in individual targeted sequenced tumors, facilitating the integration of mutational signatures with clinical data.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identification of Relevant Genetic Alterations in Cancer using Topological Data Analysis 97%
- The DiffInvex evolutionary model for conditional somatic selection identifies chemotherapy resistance genes in 10,000 cancer genomes 97%
- The mutational signatures of formalin fixation on the human genome 97%
Similar papers in this journal
- Cancer mutational processes vary in their association with replication timing and chromatin accessibility 96%
- Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses 96%
- Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis 95%
Similar papers in this journal
- Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics 96%
- Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers 95%
- Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.